Tijuana, Mexico · Mexico
Research profile compiled by Stem Cell Navigator from public sources. Every fact carries a source and a verification status.
Research-backed provider profile. Each recorded fact is labelled Clinic says, Verified, Pending verification or Not disclosed, with the source we checked. Inclusion is not an endorsement and nothing here indicates that a treatment is safe or effective.
This is a research profile, not a provider listing. Stem Cell Navigator recorded what this provider publishes about itself, checked what could be checked against independent sources, and left everything else visibly unverified or not disclosed. Inclusion is not an endorsement.
Every field is asked of every provider in the same way. Where a provider has not published something, that absence is recorded rather than filled in.
Who the provider is and how an international patient reaches them.
No registered legal operating entity is named on the reviewed public pages.
Operates publicly as Cellular Performance Institute (CPI), also branded "CPI Stem Cells".
Mexico.
Tijuana, Baja California. The provider states the site is about 20 minutes from the San Diego border.
Avenida Pacifico No. 490, Playas de Tijuana Section Costa, Tijuana, MX 22504.
https://cellularperformanceinstitute.com/
States that patients are collected in San Diego by the provider's own drivers, that border crossing is handled for them, and that ground transport runs to and from treatment each day.
Licensing and regulatory position as claimed and as independently checked.
Describes itself as a licensed stem cell therapy hospital operating within the Translational and Advanced Medical (TAM) Center, and distinguishes itself from a "stem cell clinic".
States that it is regulated and approved by COFEPRIS (Comision Federal para la Proteccion contra Riesgos Sanitarios).
No COFEPRIS registration, licence or permit number is published on the reviewed pages.
States an in-house ISO-7 certified cellular manufacturing cleanroom operated under GMP processes. No certifying body or certificate reference is published.
States that COFEPRIS approval permits it to perform cell-based therapies that have not received FDA approval for broad clinical use in the United States.
Named clinicians responsible for care, and whether credentials were checked.
Dr. Antonio Escobedo, MD is listed as Medical Director.
Biography states a medical degree from the University of Guadalajara, an internship at Mexico City General Hospital and a residency in internal medicine, followed by a career of more than 40 years.
No public medical register entry has been checked for the named clinicians.
What the clinic offers, kept separate from any evidence context.
States use of culture-expanded mesenchymal stem cells derived from umbilical cord tissue, from a characterised master cell bank expanded under hypoxic conditions.
No exosome or extracellular vesicle offering is described on the reviewed pages.
References an in-house compound pharmacy and custom peptide manufacturing. Specific peptides and their indications are not listed.
No PRP or related orthobiologic procedure is described on the reviewed pages.
Lists hyperbaric oxygen therapy, IV NAD+, IV ozone, a Myers vitamin IV, PEMF, IV vitamin C, genetic testing and whole exome sequencing, interventional radiology, dietician consultations and psychological support.
Where the biologic comes from and how it is made and tested.
Allogeneic. States that cells are collected from donated umbilical cords following healthy live births.
Umbilical cord tissue. States a fully characterised master cell bank derived from a single umbilical cord.
No donor screening or infectious-disease testing protocol is described on the reviewed pages.
States expansion at 5% oxygen in an in-house ISO-7 cGMP cleanroom, using animal-free media, with no material purchased from outside manufacturers.
Yes. Cells are described as culture-expanded under hypoxic conditions before use.
No passage number is published.
States that all cells are produced in its own in-house laboratory and that nothing is purchased from outside manufacturers.
States strict quality control protocols and release criteria before cells are used. The specific release assays are not published.
No dose in cells per administration is published.
No viability figure is published.
How treatment is actually administered.
States intravenous delivery for systemic effect, intrathecal delivery for neurological conditions, and targeted injection guided by interventional radiology.
States that most patients are treated once, and that an additional treatment is normally needed only in very severe cases.
States interventional radiology capability for targeted delivery to specific joints or tissues.
A five-day protocol is described.
The stated five-day package includes a blood work panel, x-rays, hyperbaric oxygen therapy, IV NAD+, IV ozone, a Myers vitamin IV and PEMF therapy alongside the cell therapy protocol. MRI is stated to be excluded.
Clinic-stated scope only. This section never implies evidence or efficacy.
States anti-aging and longevity, sports and orthopedic injuries, autoimmune disease, neurological disorders, disc degeneration, chronic pain, and cellular optimisation.
States that it does not treat cancer and refers cancer enquiries to the TAM Center.
No statement about accepting patients under 18 appears on the reviewed pages.
States a consultation reviewing medical history, current health status and treatment goals, and that certain contraindications may exclude a patient.
Sourced evidence context. Kept structurally separate from the Evidence Grade.
No trial registry entry tied to this provider was located.
States that it maintains clinical data on patient outcomes. No outcome dataset, method or aggregate result has been published.
Process and capability, not a safety assessment.
Lists active infections, certain cancers and severe immunosuppression among conditions that may contraindicate treatment.
No adverse-event recording or reporting process is described on the reviewed pages.
States follow-up calls after the patient returns home, review of post-treatment exams and imaging, and an aftercare telemedicine programme.
Pricing as disclosed. Absence of a published price is itself recorded.
No price is published on the reviewed pages.
A five-day inpatient package is described. No price is published for it.
Stated inclusions are hotel accommodation, all ground transportation including border crossing handling, breakfast and lunch, a blood work panel, x-rays, hyperbaric oxygen therapy, IV NAD+, IV ozone, a Myers vitamin IV, PEMF therapy and the cell therapy protocol.
MRI imaging is stated to be excluded and performed at an outside facility when required.
What a travelling patient needs to plan.
States that patients are collected in San Diego by the provider's own drivers, that border crossing is handled, and that a driver transports patients to and from treatment daily.
States accommodation at the Hyatt hotel in the Tijuana restaurant district as part of the package.
Five days.
This profile records what a provider publishes about itself and what independent sources confirm. Stem Cell Navigator does not provide medical advice, diagnosis or treatment, does not endorse any provider, and a recorded claim is not evidence that a treatment works.